Increasing evidence points to a causative role for amyloid-beta peptide (Abeta) in the pathogenesis of Alzheimer's disease (AD). Thus, mechanisms through which Abeta affects cellular properties have come under intensive study. Higher concentrations of Abeta(1-40/42), present later in the course of AD, form aggregates and fibrils which nonspecifically damage membranes of virtually any cell. Earlier in AD, when lower levels of Abeta are present, specific interactions of Abeta with particular cells, as well as sensitive subcellular loci, could also mediate cellular toxicity. We have identified a novel endoplasmic reticulum-associated Abeta binding protein termed ERAB which has properties of a b-hydroxyacyl-Coenzyme A dehydrogenase/short-chain alcohol dehydrogenase. Recombinant human ERAB binds Abeta(1-40/42) specifically, though it does not interact with beta-amyloid precursor protein (betaAPP) or forms of Abeta containing C-terminal amino acids from the precursor. ERAB, constitutively produced by neuroblastoma cells, was co-immunoprecipitated with Abeta; following exposure of cultures to exogenous Abeta, ERAB was rapidly redistributed to the inner aspect of the plasma membrane. Toxicity of Abeta to neuroblastoma cells was prevented by liposome-mediated introduction of blocking anti-ERAB F(ab')2 into the cells, and was enhanced by overexpression of ERAB in COS cells. We propose that ERAB is a critical intracellular target potentiating Abeta-mediated cellular perturbation and, ultimately, cytotoxicity. We hypothesized that Abeta influences ERAB by effecting ERAB translocation to the plasma/nuclear membrane, where induction of cell stress, marked by generation of toxic aldehydes and events triggering apoptosis, occurs.
Our first aim i s to determine the contribution of ERAB enzymatic activity and ERAB binding to Abeta on cytotoxicity by analyzing ERAB-Abeta-induced generation of toxic aldehydes and apoptosis.
Our second aim i s to analyze the contribution of ERAB to Abeta-induced cell stress using transgenic mice; we hypothesize that mice with targeted overexpression of ERAB will display exaggerated cytotoxicity in an Abeta-rich environment, and that this will be further exacerbated by ischemic stress. The long-term goal of this wok is to determine if ERAB is an important cellular cofactor for Abeta cytotoxicity, in order to assess whether inhibition of ERAB might be a novel neuroprotective strategy for future drug development.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG016736-01
Application #
2833962
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Oliver, Eugene J
Project Start
1999-06-01
Project End
2004-05-31
Budget Start
1999-06-01
Budget End
2000-05-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Physiology
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Chen, Xi; Walker, Douglas G; Schmidt, Ann Marie et al. (2007) RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease. Curr Mol Med 7:735-42
Chen, John Xi; Yan, Shi Du (2007) Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide. Expert Rev Neurother 7:1517-25
Yan, Yilin; Liu, Yangzhong; Sorci, Mirco et al. (2007) Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction. Biochemistry 46:1724-31
Chen, Xi; Stern, David; Yan, Shi Du (2006) Mitochondrial dysfunction and Alzheimer's disease. Curr Alzheimer Res 3:515-20
Yan, Shi Du; Xiong, Wen-Cheng; Stern, David M (2006) Mitochondrial amyloid-beta peptide: pathogenesis or late-phase development? J Alzheimers Dis 9:127-37
Chen, Xi; Yan, Shi Du (2006) Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease. IUBMB Life 58:686-94
Caspersen, Casper; Wang, Ning; Yao, Jun et al. (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19:2040-1
Takuma, Kazuhiro; Yao, Jun; Huang, Jianmin et al. (2005) ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J 19:597-8
Yan, Shi Du; Stern, David M (2005) Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Int J Exp Pathol 86:161-71
Lustbader, Joyce W; Cirilli, Maurizio; Lin, Chang et al. (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304:448-52

Showing the most recent 10 out of 16 publications